COVID-19 related anagen effluvium.

We present a patient with COVID-19 related anagen effluvium. The patient was treated with and responded to low dose systemic steroids to treat an accompanying extensive COVID-19-related urticaria and maculopapular rash. PMID: 32628051 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32628051?dopt=Abstract

Source: Journal of Dermatological Treatment - July 8, 2020 Category: Dermatology Tags: J Dermatolog Treat Source Type: research

More News: COVID-19 | Dermatology | Hives | Skin